Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.

Saved in:
Bibliographic Details
Title: Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.
Authors: Hörner M; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Tretschock LM; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany., John N; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany., Ziegler P; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Häberle L; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany., Uhrig S; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Goossens C; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Amann N; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Cieslik JP; Department of Gynecology and Obstetrics, Center of Integrated Oncology ABCD, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Moorenstrasse 5, Düsseldorf, Germany., Dannehl D; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Deutsch TM; Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany., Dimpfl M; Department of Gynecology and Obstetrics, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Ehlert M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Eichstädt K; Department of Gynecology, University Hospital Halle, Halle, Germany., Englisch A; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Köpke MB; Department of Obstetrics and Gynaecology, University Hospital Augsburg, Augsburg, Germany., Krückel A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Link T; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Müller A; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Reinhardt K; Department of Gynecology, University Hospital Halle, Halle, Germany., Roth J; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas Hospital St. Josef, University of Regensburg, Regensburg, Germany., Schäffler H; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Sych L; National Center for Tumor Diseases, University Hospital and German Cancer Research Center Heidelberg, Heidelberg, Germany., Tegeler CM; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Wichmann C; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Banys-Paluchowski M; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Luebeck, Germany., Princk H; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Luebeck, Germany., Rody A; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Luebeck, Germany., Brucker SY; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Ditsch N; Department of Obstetrics and Gynaecology, University Hospital Augsburg, Augsburg, Germany., Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.; Cancer Center Kempten/Allgäu (CCKA), Klinikum Kempten, Kempten, Germany., Fehm T; Department of Gynecology and Obstetrics, Center of Integrated Oncology ABCD, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Moorenstrasse 5, Düsseldorf, Germany., Hack CC; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany., Hadji P; Frankfurt Center for Bone Health and Endocrinology, Frankfurt Am Main, Germany., Hein A; Department of Gynecology, Klinikum Esslingen GmbH, Esslingen, Germany., Janni WW; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany., Kolberg HC; Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany., Lüftner D; Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Medical University of Brandenburg Theodor-Fontane, Rüdersdorf Bei Berlin, Germany., Lux MP; Department of Gynecology and Obstetrics, Frauenklinik St. LouiseSt. Josefs-KrankenhausVincenz Kliniken GmbH, PaderbornSalzkottenPaderborn, Germany., Müller V; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center Heidelberg, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Taran FA; Department of Gynecology and Gynecologic Oncology, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Medical Faculty and University Clinic of Cologne, University of Cologne, Cologne, Germany., Tesch H; Oncology Practice, Bethanien Hospital, Frankfurt Am Main, Germany., Wallwiener D; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Marmé F; Department of Gynecology and Obstetrics, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Seitz S; Department of Obstetrics and Gynecology, University Medical Center Regensburg, Caritas Hospital St. Josef, University of Regensburg, Regensburg, Germany., Belleville E; ClinSol GmbH & Co KG, Würzburg, Germany., Hartkopf A; Department of Gynecology and Obstetrics, University Hospital Tübingen, Tuebingen, Germany., Michel LL; National Center for Tumor Diseases, University Hospital and German Cancer Research Center Heidelberg, Heidelberg, Germany., Wallwiener M; Department of Gynecology, University Hospital Halle, Halle, Germany., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. peter.fasching@uk-erlangen.de., Tauber N; Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Luebeck, Germany.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2026 Apr 02; Vol. 217 (1). Date of Electronic Publication: 2026 Apr 02.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7217
DOI:10.1007/s10549-026-07939-z